ImageNet classification with deep convolutional neural networks
Alex Krizhevsky, Ilya Sutskever et al.
0
Citations
0
Influential Citations
Briefings in Bioinformatics
Venue
2024
Year
Abstract CRISPR Cas-9 is a groundbreaking genome-editing tool that harnesses bacterial defense systems to alter DNA sequences accurately. This innovative technology holds vast promise in multiple domains like biotechnology, agriculture and medicine. However, such power does not come without its own peril, and one such issue is the potential for unintended modifications (Off-Target), which highlights the need for accurate prediction and mitigation strategies. Though previous studies have demonstrated improvement in Off-Target prediction capability with the application of deep learning, they often struggle with the precision-recall trade-off, limiting their effectiveness and do not provide proper interpretation of the complex decision-making process of their models. To address these limitations, we have thoroughly explored deep learning networks, particularly the recurrent neural network based models, leveraging their established success in handling sequence data. Furthermore, we have employed genetic algorithm for hyperparameter tuning to optimize these models’ performance. The results from our experiments demonstrate significant performance improvement compared with the current state-of-the-art in Off-Target prediction, highlighting the efficacy of our approach. Furthermore, leveraging the power of the integrated gradient method, we make an effort to interpret our models resulting in a detailed analysis and understanding of the underlying factors that contribute to Off-Target predictions, in particular the presence of two sub-regions in the seed region of single guide RNA which extends the established biological hypothesis of Off-Target effects. To the best of our knowledge, our model can be considered as the first model combining high efficacy, interpretability and a desirable balance between precision and recall.
CRISPR-Cas9 is a revolutionary genome-editing tool with immense potential, but off-target effects pose significant safety risks. Accurate prediction of off-target sites is critical for therapeutic applications and basic research. While deep learning has improved prediction accuracy, previous models often suffer from a precision-recall trade-off and lack interpretability, making them less reliable and harder to trust in clinical settings.
CRISPR-DIPOFF addresses these gaps by not only improving performance but also providing interpretable insights. The identification of two sub-regions in the seed region of sgRNA extends the biological understanding of off-target mechanisms, which could inform better guide design and reduce unintended edits. This dual focus on efficacy and interpretability sets a new standard for computational tools in genomics.
The paper reports significant performance improvements over current state-of-the-art methods, though specific metrics (e.g., AUC, precision, recall) are not detailed in the abstract. The key achievement is a better balance between precision and recall, meaning fewer false positives and false negatives. The interpretability analysis provides a detailed understanding of the factors driving predictions, with the discovery of two sub-regions in the seed region being a notable finding.
CRISPR-DIPOFF represents a step forward in making deep learning models for genomics both powerful and interpretable. By combining high efficacy with interpretability, it addresses a common criticism of deep learning as a 'black box.' This work could influence future model development in other biological sequence prediction tasks, encouraging the integration of interpretability from the outset. The biological insights may also guide experimental validation and improve CRISPR design tools, ultimately enhancing the safety and efficacy of genome editing.
Alex Krizhevsky, Ilya Sutskever et al.
Ashish Vaswani, Noam Shazeer et al.
Douglas M. Bates, Martin Mächler et al.
Diederik P. Kingma, Jimmy Ba